Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine-Cardiovascular Disease Section, University of Pisa, 56100 Pisa, Italy.
Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine-Surgery Section, University of Pisa, 56100 Pisa, Italy.
Int J Mol Sci. 2021 Nov 28;22(23):12874. doi: 10.3390/ijms222312874.
The mobilization of endothelial progenitor cells (EPCs) into circulation from bone marrow is well known to be present in several clinical settings, including acute coronary syndrome, heart failure, diabetes and peripheral vascular disease. The aim of this review was to explore the current literature focusing on the great opportunity that EPCs can have in terms of regenerative medicine.
众所周知,内皮祖细胞(EPCs)从骨髓动员到循环中存在于几种临床情况下,包括急性冠状动脉综合征、心力衰竭、糖尿病和外周血管疾病。本综述的目的是探讨目前关于 EPC 在再生医学方面的巨大机遇的文献。